NEW YORK, Dec 12 - Bio-Rad Laboratories and Luminex said Tuesday they had entered into an agreement to jointly commercialize a system for drug discovery applications based on Luminex's LabMAP technology.

Bio-Rad has incorporated Luminex's microsphere-based assay technology and reader into its Bio-Plex Protein Array System. The new product, which will be available in the first quarter of 2001, is the outcome of a two-year collaboration between the companies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.